ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Feasibility Trial to Investigate the Safety and Between-group Effect Size of STIMULAN VG and Standard of Care (SoC) in Participants With Diabetic Foot Osteomyelitis

ClinicalTrials.gov ID: NCT05539963

Public ClinicalTrials.gov record NCT05539963. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 3:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center, Randomized, Controlled Feasibility Trial of STIMULAN VG and Debridement With an Abbreviated Course of Systemic Antibiotics to Debridement and a Full Course of Systemic Antibiotics for the Treatment of Diabetic Foot Osteomyelitis

Study identification

NCT ID
NCT05539963
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Biocomposites Ltd
Industry
Enrollment
61 participants

Conditions and interventions

Interventions

  • STIMULAN VG Drug
  • Systemic Antibiotics Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 22, 2023
Primary completion
Jun 19, 2025
Completion
Dec 29, 2025
Last update posted
Jun 23, 2025

2023 – 2025

United States locations

U.S. sites
10
U.S. states
6
U.S. cities
9
Facility City State ZIP Site status
Titan Clinical Research Mesa Arizona 85202
Axsendo Clinical Research Phoenix Arizona 85024
Perseverance Research Center, LLC Scottsdale Arizona 85253
Advanced Footcare LLC Scottsdale Arizona 85260
NEA Baptist Clinic Jonesboro Arkansas 72405
Viable Clinical Research Henderson Nevada 89014
Equitable Health Partners - NJ Mountainside New Jersey 07092
Mount Sinai West New York New York 10019
UNC School Medicine Chapel Hill North Carolina 27599
Seaside Clinical Research Institute Wilmington North Carolina 28412

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05539963, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2025 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05539963 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →